| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.29 | 9e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |